TherapeuticsMD, Inc. (NYSE: TXMD) announced today the pricing of a previously announced underwritten secondary public offering of 9,000,000 shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE